AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 20163-90-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 20163-90-0
Also known as: 2,3-dibromobutane-1,4-diol, 1947-58-6, 20163-90-0, 1,4-butanediol, d,l-2,3-dibromo-, 1,4-butanediol, 2,3-dibromo-, (+,-)-, Dl-2,3-dibromo-1,4-butanediol
Molecular Formula
C4H8Br2O2
Molecular Weight
247.91  g/mol
InChI Key
OXYNQEOLHRWEPE-UHFFFAOYSA-N

1 2D Structure

CAS 20163-90-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3-dibromobutane-1,4-diol
2.1.2 InChI
InChI=1S/C4H8Br2O2/c5-3(1-7)4(6)2-8/h3-4,7-8H,1-2H2
2.1.3 InChI Key
OXYNQEOLHRWEPE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(C(C(CO)Br)Br)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 2,3-dibromobutane-1,4-diol

2. 1947-58-6

3. 20163-90-0

4. 1,4-butanediol, D,l-2,3-dibromo-

5. 1,4-butanediol, 2,3-dibromo-, (+,-)-

6. Dl-2,3-dibromo-1,4-butanediol

7. 1,4-butanediol, 2,3-dibromo-, (r*,r*)-(.+/-.)-

8. Brn 1719778

9. Einecs 217-750-1

10. 1,4-butanediol, 2,3-dibromo-

11. (r*,r*)-(1)-2,3-dibromobutane-1,4-diol

12. 4-01-00-02522 (beilstein Handbook Reference)

13. Schembl373823

14. Dtxsid70869065

15. 2,3-dibromo-1,4-butanediol #

16. Baa94758

17. Mfcd00011549

18. 2,3-dibromo-1,4-butanediol, 99%

19. Akos015915044

20. (+/-)-2,3-dibromo-1,4-butanediol

21. .+/-.-2,3-dibromo-1,4-butanediol

22. As-14411

23. Cs-0336551

24. Ft-0609513

25. Ft-0659513

26. F16799

27. A813749

28. A879800

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 247.91 g/mol
Molecular Formula C4H8Br2O2
XLogP30.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass247.88706 g/mol
Monoisotopic Mass245.88910 g/mol
Topological Polar Surface Area40.5 Ų
Heavy Atom Count8
Formal Charge0
Complexity52
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
20163-90-0
2,3-Dibromobutane-1,4-diol
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY